Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Dr. Valery Alakhov, Ph.D. serves as Vice-President of Research & Development and Chief Scientific Officer of Supratek Pharma Inc. Dr. Alakhov is a co-founder of Supratek and co-inventor of the Biotransport_ and SP-MET-X_ technology platforms. Dr. Alakhov has published extensively in the areas of oncology, polymer chemistry, drug delivery and nanomedicines, and has over 70 scientific publications in peer-reviewed journals. He has more than 20 years experience as leader of highly productive research and development teams that filed 26 US patents and has developed a pipeline of eight novel product candidates against MDR and metastatic cancers. He served as a Director of Supratek Pharma Inc. since 1994. He holds a Ph.D in molecular biology at the Institute of Molecular Biology, USSR Academy of Sciences and an M.Sc. in organic chemistry from the Moscow Institute of Fine Chemical Technology.
Dr. Valery’s research interests include molecular biology, organic chemistry and drug delivery.
Evgueni Klinski, Alexandre Semov, Xu Yan, Valery Alakhov, Ekaterina Muyzhnek and Vsevolod Kiselev
Research Article: J Nanomedine Biotherapeutic Discov 2013, 3: 117
Vsevolod Kiselev, Eugenii Klinskiy, Shengmin Lee, Ekaterina Muyzhnek, Alexander Semov and Valery Alakhov
Research Article: J Nanomed Nanotechnol 2013, 4:162